Exelixis, Inc. Common Stock

EXEL US30161Q1040

💰
Capitalization
Mid-cap

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
-11% -16% 47% 39% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
76
🙍
Insiders
15
Person Price Shares Total Published Completed
Wyszomierski Jack L
 43.09
USD 		7,535
Sold 		324,683
USD 		03/06/2025 03/06/2025
Wyszomierski Jack L
 43.09
USD 		7,535
Sold 		324,683
USD 		03/06/2025 03/06/2025
Eckhardt Sue Gail
 42.74
USD 		18,834
Sold 		804,965
USD 		02/06/2025 02/06/2025
Eckhardt Sue Gail
 42.74
USD 		18,834
Sold 		804,965
USD 		02/06/2025 02/06/2025
Eckhardt Sue Gail
 43.67
USD 		4
Sold 		175
USD 		02/06/2025 02/06/2025
Eckhardt Sue Gail
 43.67
USD 		4
Sold 		175
USD 		02/06/2025 02/06/2025
Heyman Tomas J.
 44.29
USD 		4,544
Sold 		201,254
USD 		21/05/2025 21/05/2025
Heyman Tomas J.
 44.29
USD 		4,544
Sold 		201,254
USD 		21/05/2025 21/05/2025
Heyman Tomas J.
 44.29
USD 		4,544
Sold 		201,254
USD 		21/05/2025 21/05/2025
Haley Patrick J.
EX VP 		44.06
USD 		34,387
Sold 		1,515,091
USD 		20/05/2025 20/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Exelixis, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
19% 45% 47% 71% 39% 16% 519%
Last 52W Low 52W High All-Time Low All-Time High β
39.63 34.13 46.26 34.13 46.26
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Haley Patrick J. 17 22,974,621.90 1,351,448.35 12/12/2023 20/05/2025
Senner Christopher J. 4 13,658,157.96 3,414,539.49 09/08/2024 16/05/2025
Hessekiel Jeffrey 11 11,855,350.00 1,077,759.09 30/11/2023 15/05/2025
Aftab Dana 7 7,480,487.03 1,068,641.00 07/08/2024 01/05/2025
Peterson Amy C. 2 6,618,249.44 3,309,124.72 16/05/2025 16/05/2025
Poste George 6 4,621,181.89 770,196.98 21/05/2024 16/05/2025
Papadopoulos Stelios 6 4,393,554.50 732,259.08 20/05/2024 15/05/2025
Smith Julie 3 3,380,612.70 1,126,870.90 21/05/2024 28/02/2025
Eckhardt Sue Gail 6 2,015,391.04 335,898.51 14/02/2025 02/06/2025
Freire Maria C 2 1,760,463.16 880,231.58 14/08/2024 14/02/2025
Wyszomierski Jack L 5 1,396,535.21 279,307.04 13/05/2024 03/06/2025
Oliver Bob 1 694,600.75 694,600.75 25/02/2025 25/02/2025
Heyman Tomas J. 3 603,761.28 201,253.76 21/05/2025 21/05/2025
Garber Alan M 1 461,112.05 461,112.05 21/03/2024 21/03/2024
Beckerle Mary C 2 425,878.38 212,939.19 14/02/2025 14/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
HUNTSMAN CORPORATION US4470111075 HUN

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.